Identification of novel reaction products of methylene-bis-phenylisocyanate ("MDI") with oxidized glutathione in aqueous solution and also during incubation of MDI with a murine hepatic S9 fraction.
Identification of novel reaction products of methylene-bis-phenylisocyanate ("MDI") with oxidized glutathione in aqueous solution and also during incubation of MDI with a murine hepatic S9 fraction.
复制标题
鉴定亚甲基双苯基异氰酸酯(“MDI”)与氧化型谷胱甘肽在水溶液中以及在 MDI 与鼠肝 S9 级分孵育期间的新反应产物。
DOI:
10.1016/j.tiv.2016.07.011
复制
发表时间:
2016
期刊:
影响因子:
--
通讯作者:
Nassar,AF
中科院分区:
文献类型:
--
作者:
Wisnewski,AV;Liu,J;Nassar,AF
Methylene diphenyl diisocyanate (MDI) is an important industrial chemical and asthmagenic respiratory sensitizer, however its metabolism remains unclear. In this study we used LC-MS and LC-MS/MS to identify novel reaction products of MDI with oxidized glutathione (GSSG), including an 837m/z[M + H]+ion corresponding to GSSG bound (via one of its N-termini) to partially hydrolyzed MDI, and an 863m/z[M + H]+ion corresponding to GSSG cross-linked by MDI (via its two γ-glutamine N-termini). Further studies with heavy isotope labeled and native reduced glutathione (GSH) identified an [M + H]+ion corresponding to previously described mono(GSH)-MDI, and evidence for “oligomeric” GSH-MDI conjugates. This study also investigated transformational changes in MDI after incubation with an S9 fraction prepared from murine liver. LC-MS analyses of the S9 reaction products revealed the formation of [M + H]+ions withm/z's and retention times identical to the newly described GSSG-MDI (837 and 863) conjugates and the previously described mono(GSH)-MDI conjugate. Together the data identify novel biological transformations of MDI, which could have implications for exposure-related health effects, and may help target future in vivo studies of metabolism.